Evidence map›Paper›PMID 40634299›Full record

ArticleCell death & disease2025

M

Jianfeng Zhang, Guilian Cao, Feng Li, Siyu Tang, Chenxi Wu, Min Jiang, Jingxin Ye, Shaoqing Ju, Fei Qian, Weifeng Ding

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jianfeng Zhang *Department of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China.ORCID http://orcid.org/0009-0005-1154-8092
Guilian Cao *Department of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China.
Feng Li *Laboratory Medicine Center, The Sixth People's Hospital of Nantong (Affiliated Nantong Hospital of Shanghai University), Nantong, Jiangsu Province, China.
Siyu TangDepartment of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China.
Chenxi WuDepartment of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China.
Min JiangDepartment of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China.
Jingxin YeDepartment of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China.
Shaoqing JuDepartment of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China.ORCID http://orcid.org/0000-0001-7448-2020
Fei QianDepartment of Gastrointestinal Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China. qianfeint@163.com.ORCID http://orcid.org/0009-0002-1124-8565
Weifeng DingDepartment of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu Province, China. dwf@ntu.edu.cn.ORCID http://orcid.org/0000-0003-1713-3275

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81974313, 82472364
6 · The paper itself

Abstract

Non-coding RNAs (ncRNAs) have important regulatory functions similar to traditional oncogenes or tumor suppressor genes. Our previous research found a novel pan-cancer downexpressed ncRNA, PANC754. However, its function and underlying mechanism remain obscure in colorectal cancer (CRC). In this study, in vitro and in vivo experiments were performed to determine the function of PANC754. Loss and gain of function experiments, molecular docking experiments, and bioinformatic analysis were utilized to visualize its pathway. Co-culture system was leveraged to explore its effect on synergetic immune checkpoint blockage against CRC. Through a series of studies, we found that overexpressed PANC754 significantly inhibited cell viability, migration, and metastasis and induced notable apoptosis in CRC. The mechanical research found that PANC754 was the nuclear-located and its expression was regulated by m

Indexed as

Colorectal NeoplasmsImmunotherapyMethyltransferasesRNA-Binding ProteinsAnimalsApoptosisCell Line, TumorGene Expression Regulation, NeoplasticHistonesHumansLysineMiceMice, Inbred BALB CMice, NudeRNA, UntranslatedSignal TransductionH3K4me1HistonesLysineMethyltransferasesRNA-Binding ProteinsRNA, Untranslated

Identifiers

PMID40634299
PMCPMC12241656

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.